Xpan Non-Inferiority Study
Part of paid clinical trials in Morgantown, West Virginia.
- Sponsor
- West Virginia University
- Study ID
- NCT07385690
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Bariatric Surgery Candidate
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 89 Years
- Healthy Volunteers
- Not accepted
Interventions
- Xpan Trocar System — DEVICEA radially dilating trocar system intended to reduce incision trauma by gradually dilating tissue rather than cutting. Allows initial placement at 3 mm and expansion up to 12 mm as needed for surgical access.
- Standard of Care (Non-expanding Trocar) — DEVICEA surgical access device used during laparoscopic procedures that does not expand the incision site and is routinely used in standard practice.
Study Details
A trocar is a surgical instrument with a sharp point and tube and is used to create endoscopic access in the abdomen or chest where endoscopic instruments can be entered \& used in minimally invasive surgical procedures. Xpan has created an FDA Cleared radially dilating trocar (RDT) that is inserted at 3mm and can be expanded to 5mm or 12mm during surgery. The purpose of this research protocol is to demonstrate that a new FDA Cleared Xpan® radially dilating trocar (RDT) system is at least, just as effective as the existing RDT trocar systems. The procedure will be performed using a radially dilating trocar that is inserted at 3mm and can be expanded to 5mm or 12mm during surgery.
Key Dates
- Start date
- Feb 28, 2026
- Status verified
- Feb 2026
- Primary completion
- Feb 28, 2027
- Completion
- Feb 28, 2027
Study Design
- Enrollment
- 35 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Xpan Trocar SystemParticipants will undergo laparoscopic surgery using the Xpan Trocar System. Standard insertion technique will be used to create a 3 mm punch into an already gas-extended abdomen. A total of 3-5 trocars will be placed based on the type of surgery. Once placed, trocars will be radially dilated to the size necessary for the procedure, generally 2 trocars expanded to 5 mm and 2 trocars expanded to 12 mm. Final trocar size will range from 3 mm to 12 mm. Both placement and final dilated size will be documented.
- Placebo Comparator: Standard of Care (Non-expanding Trocar)Participants will undergo laparoscopic surgery using a non-expanding trocar, which is considered the institutions standard of care for the procedure. Trocar size is selected based on surgical requirements and remain fixed throughout the procedure.
Primary Outcome Measure
Percentage of Trocar slippage and Displacement [ Time Frame: Day 1- At time of procedure ]
Central Contacts
- Lawrence Tabone, MD304-293-1728
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| West Virginia University | Morgantown | West Virginia | 26505 | Lawrence Tabone, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Morgantown, WV
Related Studies
- Blood Collection Biorepository for Liver Disease ResearchRecruiting · State University of New York at Buffalo · Buffalo, New York
- Physiologic and Functional Adaptations of Insulin Sensitive TissuesEnrolling By Invitation · Vanderbilt University Medical Center · Nashville, Tennessee
- Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter RegistryRecruiting · Weill Medical College of Cornell University · New York, New York
- Gut Microbiome and Sex as Risk Factors for Kidney Stones After Bariatric SurgeryRecruiting · University of Chicago · Chicago, Illinois